HB 683

Bill Subjects

Actuarial Analysis Children And Minors Drugs And Medicines Education, Higher Effective Dates, Delayed Health Benefit Plan Mandate Insurance, Health Local Mandate Medicaid Mental Health Reproductive Issues State Employee Health Plan Mandate State Employees Women

Abstract

Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for FDA-approved prescription drugs for the treatment of postpartum mood disorders; allow the suspension of the coverage requirement for FDA-approved prescription drugs for the treatment of postpartum mood disorders under qualified health plans if cost defrayment required by the state; amend KRS 205.522, 205.6485, 18A.225, and 164.2871 to require Medicaid, Kentucky Children's Health Insurance Program, the state health employee health plan, and a self-insured employer group health plan provided by a state postsecondary education institution to its employees to comply; direct that provisions apply to health benefit plans issued on or after January 1, 2026; EFFECTIVE January 1, 2026.